FTSE 100 7220.39 +0.00% FTSE 250 INDEX 18211.63 -0.16% FTSE ALL-SHARE 3915.01 -0.02% FTSE AIM INDEX 872.34 +0.02% 
UK Market News
Posted By: Warren Smith
Warren Smith

Warren has previously spent over 5 years as a trader on the London Stock Exchange and is now semi-retired. He works on a part time basis for UK Market News specialising in quicker moving active shares with a short term view on investment opportunities and trends.

On Tuesday Northland Capital reiterated its target price on Evgen Pharma Plc (LON:EVG) shares issuing the company with a ‘Buy’ rating. Northland Capital gave the share price of Evgen Pharma Plc a price target of 97 meaning the broker expects a potential upside of 340.91% from Evgen Pharma Plc’s current market price of 22. Evgen...

On Tuesday Numis reiterated its target price on Ashmore Group PLC (LON:ASHM) shares issuing the company with a ‘Hold’ rating. Numis gave the share price of Ashmore Group PLC a price target of 290 meaning the broker expects a potential downside of -3.59% from Ashmore Group PLC’s current market price of 300.8. Ashmore Group PLC has...

Dechra Pharmaceuticals PLC (LON:DPH) yesterday was the subject of a new research report issued by Numis in which it was reiterated as ‘Add’ by analysts at the firm. Numis noted a target price of 1520 on Dechra Pharmaceuticals PLC’s shares. According to this price target, it now means the analyst believes there is a potential increase...

According to a report issued to investors by Numis on Tuesday, shares of Ergomed Plc (LON:ERGO) had their rating reiterated by analysts to ‘Buy’. The analyst stated that the investment firm has set a price target of 267 on shares of LON:ERGO. Based on the brokers price target of 267, this means Numis believes there is a potential increase...

Following an update released by analysts at Numis on Tuesday the broker has now set a ‘Add’ rating on shares of Jupiter Fund Management plc (LON:JUP) with a price target of 533. On Tuesday Numis reiterated its target for shares of Jupiter Fund Management plc as ‘Add’ recommending a target price of 533 for investors; potentially...

According to a report issued to investors by Numis on Tuesday, shares of Learning Technologies Group (LON:LTG) had their rating retained by analysts to ‘Buy’. The analyst stated that the investment firm has set a price target of 46 on shares of LON:LTG. Based on the brokers price target of 46, this means Numis believes there is a potential...

River And Mercantile Group (LON:RIV) yesterday was the subject of a new research report issued by Numis in which it was retained as ‘Hold’ by analysts at the firm. Numis noted a target price of 240 on River And Mercantile Group’s shares. According to this price target, it now means the analyst believes there is a potential increase...

On Tuesday Numis retained its target price on Velocys (LON:VLS) shares issuing the company with a ‘Buy’ rating. Numis gave the share price of Velocys a price target of 107 meaning the broker expects a potential upside of 121.02% from Velocys’s current market price of 48.41. Velocys has 142,748,000 shares outstanding at the moment...

On Tuesday analysts at Liberum Capital retained Spire Healthcare Group’s (LON:SPI) shares as ‘Buy’ in a research note issued to investors. Following Liberum Capital’s latest price target of 400 on the business this highlights that the broker now believes there is an increase of 27.87% from Spire Healthcare Group’s current share...

On Tuesday analysts at Liberum Capital reiterated AstraZeneca PLC’s (LON:AZN) shares as ‘Hold’ in a research note issued to investors. Following Liberum Capital’s latest price target of 5200 on the business this highlights that the broker now believes there is an increase of 14.01% from AstraZeneca PLC’s current share price of...